Target Price | $200.94 |
Price | $195.74 |
Potential | 2.66% |
Number of Estimates | 36 |
36 Analysts have issued a price target Texas Instruments 2026 . The average Texas Instruments target price is $200.94. This is 2.66% higher than the current stock price. The highest price target is $273.00 39.47% , the lowest is $126.25 35.50% . | |
A rating was issued by 44 analysts: 18 Analysts recommend Texas Instruments to buy, 22 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Texas Instruments stock has an average upside potential 2026 of 2.66% . Most analysts recommend the Texas Instruments stock at Hold. |
40 Analysts have issued a sales forecast Texas Instruments 2025 . The average Texas Instruments sales estimate is $17.9b . This is 7.09% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $19.1b 14.71% , the lowest is $17.0b 2.19% .
This results in the following potential growth metrics:
2024 | $15.6b | 10.72% |
---|---|---|
2025 | $17.9b | 14.17% |
2026 | $19.7b | 10.26% |
2027 | $21.6b | 9.59% |
2028 | $23.4b | 8.51% |
2029 | $25.6b | 9.16% |
2030 | $28.0b | 9.73% |
21 Analysts have issued an Texas Instruments EBITDA forecast 2025. The average Texas Instruments EBITDA estimate is $8.2b . This is 8.19% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $9.5b 25.24% , the lowest is $7.6b 0.79% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $6.9b | 5.59% |
---|---|---|
2025 | $8.2b | 18.49% |
2026 | $9.7b | 18.39% |
2027 | $11.3b | 15.90% |
2028 | $12.5b | 11.20% |
2029 | $14.7b | 17.53% |
2024 | 44.25% | 5.74% |
---|---|---|
2025 | 45.92% | 3.78% |
2026 | 49.31% | 7.38% |
2027 | 52.15% | 5.76% |
2028 | 53.44% | 2.47% |
2029 | 57.54% | 7.67% |
40 Texas Instruments Analysts have issued a net profit forecast 2025. The average Texas Instruments net profit estimate is $5.1b . This is 2.69% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $5.6b 12.00% , the lowest is $4.8b 4.43% .
This results in the following potential growth metrics and future Net Margins:
2024 | $4.8b | 26.28% |
---|---|---|
2025 | $5.1b | 7.85% |
2026 | $6.1b | 19.14% |
2027 | $7.3b | 18.94% |
2028 | $9.2b | 26.25% |
2029 | $10.3b | 11.91% |
2024 | 30.53% | 17.43% |
---|---|---|
2025 | 28.84% | 5.53% |
2026 | 31.16% | 8.04% |
2027 | 33.82% | 8.54% |
2028 | 39.35% | 16.35% |
2029 | 40.34% | 2.52% |
40 Analysts have issued a Texas Instruments forecast for earnings per share. The average Texas Instruments EPS is $5.67 . This is 3.28% higher than earnings per share in the financial year 2024. The highest EPS forecast is $6.18 12.57% , the lowest is $5.27 4.01% .
This results in the following potential growth metrics and future valuations:
2024 | $5.20 | 26.45% |
---|---|---|
2025 | $5.67 | 9.04% |
2026 | $6.75 | 19.05% |
2027 | $8.03 | 18.96% |
2028 | $10.14 | 26.28% |
2029 | $11.34 | 11.83% |
Current | 35.65 | 4.19% |
---|---|---|
2025 | 34.55 | 3.10% |
2026 | 29.00 | 16.06% |
2027 | 24.38 | 15.93% |
2028 | 19.31 | 20.80% |
2029 | 17.26 | 10.62% |
Based on analysts' sales estimates for 2025, the Texas Instruments stock is valued at an EV/Sales of 10.45 and an P/S ratio of 9.97 .
This results in the following potential growth metrics and future valuations:
Current | 11.19 | 9.90% |
---|---|---|
2025 | 10.45 | 6.60% |
2026 | 9.48 | 9.31% |
2027 | 8.65 | 8.75% |
2028 | 7.97 | 7.84% |
2029 | 7.30 | 8.39% |
2030 | 6.65 | 8.87% |
Current | 10.67 | 12.25% |
---|---|---|
2025 | 9.97 | 6.62% |
2026 | 9.04 | 9.31% |
2027 | 8.25 | 8.75% |
2028 | 7.60 | 7.85% |
2029 | 6.96 | 8.39% |
2030 | 6.34 | 8.87% |
Texas Instruments...
Analyst | Rating | Action | Date |
---|---|---|---|
Wolfe Research |
Peer Perform
➜
Outperform
|
Upgrade | Jul 28 2025 |
Truist Securities |
Hold
➜
Hold
|
Unchanged | Jul 23 2025 |
Benchmark |
Buy
➜
Buy
|
Unchanged | Jul 23 2025 |
Baird |
Outperform
➜
Outperform
|
Unchanged | Jul 23 2025 |
Susquehanna |
Positive
➜
Positive
|
Unchanged | Jul 23 2025 |
Rosenblatt |
Buy
➜
Buy
|
Unchanged | Jul 23 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jul 23 2025 |
Analyst Rating | Date |
---|---|
Upgrade
Wolfe Research:
Peer Perform
➜
Outperform
|
Jul 28 2025 |
Unchanged
Truist Securities:
Hold
➜
Hold
|
Jul 23 2025 |
Unchanged
Benchmark:
Buy
➜
Buy
|
Jul 23 2025 |
Unchanged
Baird:
Outperform
➜
Outperform
|
Jul 23 2025 |
Unchanged
Susquehanna:
Positive
➜
Positive
|
Jul 23 2025 |
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Jul 23 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jul 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.